Save information for later
Sign Up

Learn About Pancreatic Ductal Adenocarcinoma

What is the definition of Pancreatic Ductal Adenocarcinoma?
Pancreatic ductal adenocarcinoma is an aggressive cancer that occurs in the linings of the tubes of the pancreas that carry enzymes to the intestines that assist with digestion.
What are the symptoms of Pancreatic Ductal Adenocarcinoma?
Early pancreatic ductal adenocarcinoma may not have any symptoms. Symptoms of pancreatic ductal adenocarcinoma may include yellowing of the skin and whites of the eyes, fatigue, dark urine, light-colored or greasy stools, itchy skin, abdominal or back pain, weight loss, nausea and vomiting, gallbladder or liver enlargement, blood clots, and diabetes.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Pancreatic Ductal Adenocarcinoma?
Treatment for pancreatic ductal adenocarcinoma includes surgery, radiation therapy, and chemotherapy.
Who are the top Pancreatic Ductal Adenocarcinoma Local Doctors?
Elite in Pancreatic Ductal Adenocarcinoma
Oncology | Hematology Oncology | Hematology
Elite in Pancreatic Ductal Adenocarcinoma
Oncology | Hematology Oncology | Hematology

The Medical College Of Wisconsin Inc

8701 Watertown Plank Rd, Room 4041 Mfrc, 
Milwaukee, WI 
Languages Spoken:
English, Malayalam
Accepting New Patients
Offers Telehealth

Ben George is an Oncologist and a Hematologist Oncology provider in Milwaukee, Wisconsin. Dr. George is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Colorectal Cancer, Pancreatectomy, and Endoscopy. Dr. George is currently accepting new patients.

Charles J. Yeo
Elite in Pancreatic Ductal Adenocarcinoma
General Surgery | Oncology
Elite in Pancreatic Ductal Adenocarcinoma
General Surgery | Oncology

Jefferson Surgery - Honickman Center

1101 Chestnut Street, Floor 8, 
Philadelphia, PA 
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Charles Yeo is an Oncologist and a General Surgeon in Philadelphia, Pennsylvania. Dr. Yeo is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Yeo is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More
Richard A. Burkhart
Elite in Pancreatic Ductal Adenocarcinoma
Surgical Oncology
Elite in Pancreatic Ductal Adenocarcinoma
Surgical Oncology

Skip Viragh Outpatient Cancer Center

201 North Broadway Street, Viragh BLDG 5th FL, Viragh BLDG 5th FL, 
Baltimore, MD 
Experience:
18+ years
Languages Spoken:
English
Offers Telehealth

Richard Burkhart, M.D., is an Associate Professor of Surgery at The Johns Hopkins Hospital with a focus on complex minimally-invasive surgery and research for cancers of the pancreas, liver and bile ducts. Dr. Burkhart received his medical degree from Boston University and completed his surgical residency and research fellowships at the Thomas Jefferson University Hospital in Philadelphia and the Cold Spring Harbor Laboratories. He is a member of several professional organizations, including the American Association of Cancer Research, the American College of Surgeons, the Society of Surgery for the Alimentary Tract, the Pancreas Club, and the Society of Surgical Oncology. Outside the operating room, Dr. Burkhart heads a multidisciplinary laboratory team dedicated to bringing next-generation precision medicine approaches into the routine clinical care of patients that we serve. He has a particular research interest in using personalized models of pancreas cancer, made from tumor during and immediately after surgical resection, to select the best chemotherapy for each patient to support long-term survival and improve rates of disease cure. The laboratory team, funded in part by the National Institutes of Health, the National Cancer Institute, the Lustgarten Foundation and Stand Up to Cancer, is also thankful to the many patients who have supported the work through philanthropic gift. Dr. Burkhart is rated as an Elite provider by MediFind in the treatment of Pancreatic Ductal Adenocarcinoma. His top areas of expertise are Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

What are the latest Pancreatic Ductal Adenocarcinoma Clinical Trials?
Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 1b Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Heterologous Prime Boost Vaccination (ATP150/ATP152/ATP162, VSV-GP154) and Ezabenlimab (BI 754091) in Patients With Pancreatic Ductal Adenocarcinoma.

Summary: This study is open to adults with advanced pancreatic cancer. The study tests a type of immunotherapy. It is a protein treatment combined with a virus that may kill cancer cells and help the immune system fight cancer. The immunotherapy is combined with a study medicine called ezabenlimab. Ezabenlimab is an antibody that may also help the immune system fight cancer. The purpose is to find the high...